Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Omeprazole 40 Mg Vial; Platifilin Solution For Injection, 2 Mg/Ml, 1 Ml; Ursodoxycholic Acid Capsules/Tablets Of 250 Mg; Lactulose, Syrup, 670 Mg/Ml, 200 Ml In Vial # 1; Sulfasalase Tablets Of 500 Mg; Pancreatin, Lipolitical Ods: 10000; Insulin Glargin, Solution For Injection, 100… Still

ВІЙСЬКОВА ЧАСТИНА А2339 Ukraine has Released a tender for Omeprazole 40 Mg Vial; Platifilin Solution For Injection, 2 Mg/Ml, 1 Ml; Ursodoxycholic Acid Capsules/Tablets Of 250 Mg; Lactulose, Syrup, 670 Mg/Ml, 200 Ml In Vial # 1; Sulfasalase Tablets Of 500 Mg; Pancreatin, Lipolitical Ods: 10000; Insulin Glargin, Solution For Injection, 100… Still in Pharmaceuticals. The tender was released on Jul 21, 2025.

Country - Ukraine

Summary - Omeprazole 40 Mg Vial; Platifilin Solution For Injection, 2 Mg/Ml, 1 Ml; Ursodoxycholic Acid Capsules/Tablets Of 250 Mg; Lactulose, Syrup, 670 Mg/Ml, 200 Ml In Vial # 1; Sulfasalase Tablets Of 500 Mg; Pancreatin, Lipolitical Ods: 10000; Insulin Glargin, Solution For Injection, 100… Still

Deadline - Aug 05, 2025

GT reference number - 113856040

Product classification - Medicinal products for the alimentary tract and metabolism

Organization Details:

  Address - Ukraine

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 113856040

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Omeprazole 40 mg Vial Platifin solution for injection, 2 mg/ml, 1 ml ursodeoxycholic acid capsules/tablets of 250 mg lactulose, syrup, 670 mg/ml, 200 ml in vial # 1 sulfasalase tablets: 500 mg. solution for injection, 100 U/ml, 3 ml Metf ormin tablets covered with a shell, 500 mg gliclazide tablets with modified release, 30 mg of glymepiride, tablets, 4 mg ascorbic acid solution for injection, 100 mg/ml for 2 mlpalis asparagias. Clopidogrel, tablets covered with a shell, 75 mg Rivoroxaban tablets, covered with a film sheath, 15 mg Rivoroxaban tablets covered with a film sheath, 20 mg Anti-ha/ml, 0.4 ml Etamzilate solution for injection, 125 mg/ml of 2 ml cyanocobalamin (vitamin B

Gt Ref Id - 113856040

Deadline - Aug 05, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database